Impact of lubiprostone on gastric emptying in healthy volunteer

Impact of lubiprostone on gastric emptying in healthy volunteer - Impact of lubiprostone on gastric emptying in healthy volunteer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022200

Enrollment

Registered

2016-05-06

Start date

2016-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric emptying

Interventions

single dose of lubiprostone 24 microgram 1 tablet single dose of lubiprostone 24 microgram 1 tablet and domperidone 10 mirigram 1 tablet no medication

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: who has neither gastrointestinal symptoms, medications taken regularly, nor past history of abdominal surgery.

Exclusion criteria

Exclusion criteria: who does not match the above condition.

Design outcomes

Primary

Measure	Time frame
Change of gastric emptying parameters after administration of lubiprostone	—

Secondary

Measure	Time frame
Gastrointestinal symptom	—

Countries

Japan

Contacts

Public ContactTakatsugu Yamamoto

Teikyo University Internal Medicine

ymmt@med.teikyo-u.ac.jp03-3964-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026